Expertise in
4
conditions

Dr. Shyam Rao

Neurology
Rhode Island Hospital
593 Eddy St, 
Providence, RI 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
Rhode Island Hospital
593 Eddy St, 
Providence, RI 

Overview

Shyam Rao is a Neurologist in Providence, Rhode Island. Dr. Rao is highly rated in 4 conditions, according to our data. His top areas of expertise are Delirium, Stroke, Subarachnoid Hemorrhage, Thrombectomy, and Craniectomy.

His clinical research consists of co-authoring 76 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Neurology

Licenses

Psychiatry & Neurology in RI

Hospital Affiliations

Henry Ford Health Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Priority Health
  • HMO
  • POS

Locations

Rhode Island Hospital
593 Eddy St, Providence, RI 02903
Other Locations
Henry Ford Hospital
2799 W Grand Blvd, Detroit, MI 48202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Enrollment Status: Recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug, Other, Radiation, Biological
Study Drugs: Atezolizumab, Cetuximab, Cisplatin, Docetaxel
Study Phase: Phase 2/Phase 3
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Enrollment Status: Completed
Publish Date: February 06, 2026
Intervention Type: Other, Biological, Radiation
Study Drugs: Cetuximab, Durvalumab
Study Phase: Phase 2/Phase 3
Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation With Weekly Cisplatin at 40 mg/m2 for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation With Weekly Cisplatin at 40 mg/m2 for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Enrollment Status: Suspended
Publish Date: January 14, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2/Phase 3
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Enrollment Status: Active_not_recruiting
Publish Date: November 19, 2025
Intervention Type: Other, Drug, Radiation
Study Drugs: Cisplatin, Fluorouracil, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 13, 2025
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
View 5 Less Clinical Trials

76 Total Publications

Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer.
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 22, 2025
Similar Doctors
Expertise in
53
conditions
Dr. Joseph Friedman
Neurology
Expertise in
53
conditions
Dr. Joseph Friedman
Neurology

Butler Hospital

345 Blackstone Blvd, 
Providence, RI 
 (600.6 miles away)
401-455-6669
Languages Spoken:
English
See accepted insurances

Joseph Friedman is a Neurologist in Providence, Rhode Island. Dr. Friedman is highly rated in 53 conditions, according to our data. His top areas of expertise are Movement Disorders, Parkinson's Disease, Tardive Dyskinesia, Secondary Parkinsonism, and Gastrostomy.

Patrick Y. Wen
Expertise in
26
conditions
Dr. Patrick Y. Wen
Neurology
Expertise in
26
conditions
Dr. Patrick Y. Wen
Neurology

Dana-Farber Cancer Institute, Center For Neuro-Oncology

450 Brookline Avenue, 
Boston, MA 
 (611.1 miles away)
617-632-2166
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Patrick Wen is a Neurologist in Boston, Massachusetts. Dr. Wen is highly rated in 26 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Expertise in
38
conditions
Dr. Scott Plotkin
Neurology
Expertise in
38
conditions
Dr. Scott Plotkin
Neurology

Office

55 Fruit St # 9, 
Boston, MA 
 (612.9 miles away)
617-724-8770
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Scott Plotkin is a Neurologist in Boston, Massachusetts. Dr. Plotkin is highly rated in 38 conditions, according to our data. His top areas of expertise are Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis, and Acoustic Neuroma.

Frequently Asked Questions about Dr. Shyam Rao

How do I make an appointment with Dr. Shyam Rao?

You can book an appointment with Dr. Shyam Rao by calling their office at 401-606-8356. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shyam Rao a top-rated expert for Delirium?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shyam Rao is classified as an Advanced expert for Delirium, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shyam Rao specialize in?

While Dr. Shyam Rao is a Neurology, they have specific expertise in Delirium, Thrombectomy, and Stroke. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Shyam Rao participate in research or clinical trials?

Yes. Dr. Shyam Rao has published 76 articles and abstracts on conditions like Delirium. You can view a list of Dr. Shyam Rao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Shyam Rao accept my insurance?

Dr. Shyam Rao accepts most major insurance plans, including Blue Cross Blue Shield and Humana. We recommend calling the office directly at 401-606-8356 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rao's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile